Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Eitel

Showing results (271-280 of 443) with videos related to

Pageof 45
Sort By:
International Journal of Cardiology|May 13, 2015
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trialGeorg Fuernau, Christian Poenisch, Ingo Eitel, et al.
Journal of the American College of Cardiology|November 6, 2024
Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI TrialHans-Josef Feistritzer, Thomas Kurz, Reinhard Vonthein, et al.
European Heart Journal. Cardiovascular Imaging|July 23, 2019
Fast manual long-axis strain assessment provides optimized cardiovascular event prediction following myocardial infarctionAndreas Schuster, Sören J Backhaus, Thomas Stiermaier, et al.
American Heart Journal|April 23, 2025
Rationale and design of the cyclosporine in Takotsubo syndrome (CIT) trialBastian Bruns, Nesrin Elsous, Ina Burghaus, et al.
Coronary Artery Disease|September 27, 2021
Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarctionBjörn Redfors, Matheus Simonato, Shmuel Chen, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom OnsetSteffen Desch, Thomas Stiermaier, Suzanne de Waha, et al.
Heart (British Cardiac Society)|March 9, 2012
Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studiesRaffaele Piccolo, Youlan L Gu, Allan Zeeberg Iversen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 25, 2014
Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trialsRaffaele Piccolo, Ingo Eitel, Allan Zeeberg Iversen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 19, 2024
Long-term risk factor management and adverse events in patients with early-onset myocardial infarction-a "real-world" studyHatim Kerniss, Luis Alberto Mata Marín, Kilian Clemens, et al.
European Heart Journal|September 20, 2015
Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trialIngo Eitel, Thomas Stiermaier, Karl P Rommel, et al.
Pageof 45

Showing results (271-280 of 443) with videos related to

Sort By:
Pageof 45
International Journal of Cardiology|May 13, 2015
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trialGeorg Fuernau, Christian Poenisch, Ingo Eitel, et al.
Journal of the American College of Cardiology|November 6, 2024
Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI TrialHans-Josef Feistritzer, Thomas Kurz, Reinhard Vonthein, et al.
European Heart Journal. Cardiovascular Imaging|July 23, 2019
Fast manual long-axis strain assessment provides optimized cardiovascular event prediction following myocardial infarctionAndreas Schuster, Sören J Backhaus, Thomas Stiermaier, et al.
American Heart Journal|April 23, 2025
Rationale and design of the cyclosporine in Takotsubo syndrome (CIT) trialBastian Bruns, Nesrin Elsous, Ina Burghaus, et al.
Coronary Artery Disease|September 27, 2021
Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarctionBjörn Redfors, Matheus Simonato, Shmuel Chen, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom OnsetSteffen Desch, Thomas Stiermaier, Suzanne de Waha, et al.
Heart (British Cardiac Society)|March 9, 2012
Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studiesRaffaele Piccolo, Youlan L Gu, Allan Zeeberg Iversen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 25, 2014
Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trialsRaffaele Piccolo, Ingo Eitel, Allan Zeeberg Iversen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 19, 2024
Long-term risk factor management and adverse events in patients with early-onset myocardial infarction-a "real-world" studyHatim Kerniss, Luis Alberto Mata Marín, Kilian Clemens, et al.
European Heart Journal|September 20, 2015
Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trialIngo Eitel, Thomas Stiermaier, Karl P Rommel, et al.
Pageof 45